Mediphage Bioceuticals Patents

Patent portfolio assigned to Mediphage Bioceuticals (verified via public assignee records). Toronto precision-genetics company; proprietary ministring DNA (msDNA) non-viral, backbone-free LCC DNA vector for gene/cell therapy. has_patents=true: patents assigned to MEDIPHAGE BIOCEUTICALS, INC. per Justia assignee page and Google Patents (e.g. 'DNA vector production system' US20160333361A1; inventor Nafiseh Nafissi); USPTO-issued patent on the msDNA platform per company. Exact count not enumerated (Justia/Google Patents pages not directly fetchable this session). No direct competitors or named customers disclosed.